1
田口鐵男他:癌と化学療法, 1994;21(12):1997-2005
2
第十八改正日本薬局方解説書, 廣川書店, 2021;C-3537-3543
3
Baker, S. D. et al.:Clin. Cancer Res., 2004;10(6):1976-1983
4
Bissery, M. C. et al.:Anti-Cancer Drugs, 1995;6(3):339-355
5
de Valeriola, D. et al.:Proceedings of the American Association for Cancer Research, 1993;34:373
6
Shou, M. et al.:Pharmacogenetics, 1998;8:391-401
7
Sparreboom, A. et al.:Drug Metab. Dispos., 1996;24(6):655-658
8
田口鐵男他:癌と化学療法, 1994;21(15):2625-2632
9
Adachi, I. et al.:British Journal of Cancer, 1996;73:210-216
10
工藤翔二他:癌と化学療法, 1994;21(15):2617-2623
11
大熨泰亮他:癌と化学療法, 1995;22(1):59-65
12
Muro, K. et al.:Annals of Oncology, 2004;15:955-959
13
Katsumata, N. et al.:British Journal of Cancer, 2005;93:999-1004
14
Naito, S. et al.:Jpn. J. Clin. Oncol., 2008;38(5):365-372
15
Tannock, I. F. et al.:New England Journal of Medicine, 2004;351(15):1502-1512
16
海外第3相臨床試験(タキソテール注:2008年8月29日承認、審査報告書)
17
Ringel, I. et al.:Journal of the National Cancer Institute, 1991;83(4):288-291
18
Bissery, M. C. et al.:Cancer Research, 1991;51(18):4845-4852
19
Bissery, M. C. et al.:Proceedings of the American Association for Cancer Research, 1994;35:327
20
Riou, J. F. et al.:Biochemical and Biophysical Research Communications, 1992;187(1):164-170
21
Tanaka, M. et al.:European Journal of Cancer, 1996;32A(2):226-230
22
Dykes, D. J. et al.:Investigational New Drugs, 1995;13:1-11
23
Kelland, L. R. et al.:Cancer Chemotherapy and Pharmacology, 1992;30(6):444-450
24
赤藤修司他:癌と化学療法, 2006;33(3):337-343
25
赤藤修司他:癌と化学療法, 2005;32(10):1437-1442
26
Kraus, L. A. et al.:Investigational New Drugs, 2003;21:259-268